• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

VIII 因子 C1 结构域上的一个膜相互作用表面与 C2 结构域共同发挥辅助因子功能。

A membrane-interactive surface on the factor VIII C1 domain cooperates with the C2 domain for cofactor function.

机构信息

Department of Medicine, Veterans Administration Boston Healthcare System, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.

出版信息

Blood. 2011 Mar 17;117(11):3181-9. doi: 10.1182/blood-2010-08-301663. Epub 2010 Dec 14.

DOI:10.1182/blood-2010-08-301663
PMID:21156843
Abstract

Factor VIII binds to phosphatidylserine (PS)-containing membranes through its tandem, lectin-homology, C1 and C2 domains. However, the details of C1 domain membrane binding have not been delineated. We prepared 4 factor VIII C1 mutations localized to a hypothesized membrane-interactive surface (Arg2090Ala/Gln2091Ala, Lys2092Ala/Phe2093Ala, Gln2042Ala/Tyr2043Ala, and Arg2159Ala). Membrane binding and cofactor activity were measured using membranes with 15% PS, mimicking platelets stimulated by thrombin plus collagen, and 4% PS, mimicking platelets stimulated by thrombin. All mutants had at least 10-fold reduced affinities for membranes of 4% PS, and 3 mutants also had decreased apparent affinity for factor X. Monoclonal antibodies against the C2 domain produced different relative impairment of mutants compared with wild-type factor VIII. Monoclonal antibody ESH4 decreased the V(max) for all mutants but only the apparent membrane affinity for wild-type factor VIII. Monoclonal antibody BO2C11 decreased the V(max) of wild-type factor VIII by 90% but decreased the activity of 3 mutants more than 98%. These results identify a membrane-binding face of the factor VIII C1 domain, indicate an influence of the C1 domain on factor VIII binding to factor X, and indicate that cooperation between the C1 and C2 domains is necessary for full activity of the factor Xase complex.

摘要

VIII 因子通过其串联的凝集素同源结构域 C1 和 C2 与含有磷脂酰丝氨酸 (PS) 的膜结合。然而,C1 结构域与膜结合的细节尚未阐明。我们制备了 4 种定位在假定的膜相互作用表面的 VIII 因子 C1 突变体(Arg2090Ala/Gln2091Ala、Lys2092Ala/Phe2093Ala、Gln2042Ala/Tyr2043Ala 和 Arg2159Ala)。使用含有 15% PS 的膜(模拟由凝血酶加胶原刺激的血小板)和 4% PS 的膜(模拟由凝血酶刺激的血小板)测量了膜结合和辅助因子活性。所有突变体与 4% PS 的膜的亲和力至少降低了 10 倍,并且 3 个突变体也降低了与因子 X 的表观亲和力。针对 C2 结构域的单克隆抗体与野生型 VIII 因子相比,对突变体产生了不同的相对损伤。单克隆抗体 ESH4 降低了所有突变体的 V(max),但仅降低了野生型 VIII 因子的膜亲和力。单克隆抗体 BO2C11 使野生型 VIII 因子的 V(max)降低了 90%,但使 3 个突变体的活性降低了 98%以上。这些结果确定了 VIII 因子 C1 结构域的一个膜结合面,表明 C1 结构域对 VIII 因子与因子 X 的结合有影响,并表明 C1 和 C2 结构域之间的协同作用是因子 Xa 复合物充分活性所必需的。

相似文献

1
A membrane-interactive surface on the factor VIII C1 domain cooperates with the C2 domain for cofactor function.VIII 因子 C1 结构域上的一个膜相互作用表面与 C2 结构域共同发挥辅助因子功能。
Blood. 2011 Mar 17;117(11):3181-9. doi: 10.1182/blood-2010-08-301663. Epub 2010 Dec 14.
2
Membrane-binding properties of the Factor VIII C2 domain.因子 VIII C2 结构域的膜结合特性。
Biochem J. 2011 Apr 1;435(1):187-96. doi: 10.1042/BJ20101797.
3
Factor VIII C1 domain residues Lys 2092 and Phe 2093 contribute to membrane binding and cofactor activity.凝血因子VIII C1结构域的赖氨酸2092和苯丙氨酸2093残基有助于膜结合和辅因子活性。
Blood. 2009 Oct 29;114(18):3938-46. doi: 10.1182/blood-2009-01-197707. Epub 2009 Aug 17.
4
Activation of factor VIII by thrombin increases its affinity for binding to synthetic phospholipid membranes and activated platelets.凝血酶对因子VIII的激活增加了其与合成磷脂膜及活化血小板结合的亲和力。
J Biol Chem. 1998 Oct 23;273(43):27918-26. doi: 10.1074/jbc.273.43.27918.
5
Conservative mutations in the C2 domains of factor VIII and factor V alter phospholipid binding and cofactor activity.VIII 因子和 V 因子的 C2 结构域中的保守突变改变了磷脂结合和辅因子活性。
Blood. 2012 Aug 30;120(9):1923-32. doi: 10.1182/blood-2012-01-408245. Epub 2012 May 21.
6
Factor VIII C1 domain spikes 2092-2093 and 2158-2159 comprise regions that modulate cofactor function and cellular uptake.VIII 因子 C1 结构域的 2092-2093 和 2158-2159 位突刺包含了调节辅助因子功能和细胞摄取的区域。
J Biol Chem. 2013 Oct 11;288(41):29670-9. doi: 10.1074/jbc.M113.473116. Epub 2013 Sep 5.
7
Four hydrophobic amino acids of the factor VIII C2 domain are constituents of both the membrane-binding and von Willebrand factor-binding motifs.凝血因子VIII C2结构域的四个疏水氨基酸是膜结合基序和血管性血友病因子结合基序的组成部分。
J Biol Chem. 2002 Feb 22;277(8):6374-81. doi: 10.1074/jbc.M104732200. Epub 2001 Nov 6.
8
Replacing the factor VIII C1 domain with a second C2 domain reduces factor VIII stability and affinity for factor IXa.用第二个 C2 结构域替换因子 VIII C1 结构域会降低因子 VIII 的稳定性和对因子 IXa 的亲和力。
J Biol Chem. 2013 Oct 25;288(43):31289-97. doi: 10.1074/jbc.M113.497289. Epub 2013 Sep 12.
9
Factor VIII/V C-domain swaps reveal discrete C-domain roles in factor VIII function and intracellular trafficking.凝血因子VIII/V的C结构域交换揭示了C结构域在凝血因子VIII功能和细胞内运输中的不同作用。
Haematologica. 2017 Apr;102(4):686-694. doi: 10.3324/haematol.2016.153163. Epub 2017 Jan 5.
10
The C1 and C2 domains of blood coagulation factor VIII mediate its endocytosis by dendritic cells.凝血因子VIII的C1和C2结构域介导其被树突状细胞内吞。
Haematologica. 2017 Feb;102(2):271-281. doi: 10.3324/haematol.2016.148502. Epub 2016 Oct 6.

引用本文的文献

1
Flow Cytometry Evaluation of Blood-Cell-Bound Surface FVIII in Hemophilia A and Thrombosis.血友病A与血栓形成中血细胞结合的表面FVIII的流式细胞术评估
Cells. 2025 Jan 8;14(2):73. doi: 10.3390/cells14020073.
2
Atomistic Mechanism of Lipid Membrane Binding for Blood Coagulation Factor VIII with Molecular Dynamics Simulations on a Microsecond Time Scale.基于微秒时间尺度分子动力学模拟的凝血因子VIII脂质膜结合的原子机制
J Phys Chem B. 2025 Feb 6;129(5):1486-1498. doi: 10.1021/acs.jpcb.4c06575. Epub 2025 Jan 22.
3
Biophysical characterization of blood coagulation factor VIII binding to lipid nanodiscs that mimic activated platelet surfaces.
模拟活化血小板表面的脂质纳米盘结合凝血因子VIII的生物物理特性研究
J Thromb Haemost. 2025 Feb;23(2):513-524. doi: 10.1016/j.jtha.2024.11.003. Epub 2024 Nov 15.
4
Structure of coagulation factor VIII bound to a patient-derived anti-C1 domain antibody inhibitor.凝血因子 VIII 与患者来源的抗 C1 结构域抗体抑制剂复合物的结构。
Blood. 2023 Jul 13;142(2):197-201. doi: 10.1182/blood.2023020181.
5
Stable binding to phosphatidylserine-containing membranes requires conserved arginine residues in tandem C domains of blood coagulation factor VIII.与含磷脂酰丝氨酸的膜稳定结合需要凝血因子 VIII 的串联 C 结构域中的保守精氨酸残基。
Front Mol Biosci. 2022 Oct 26;9:1040106. doi: 10.3389/fmolb.2022.1040106. eCollection 2022.
6
Isolated Variable Domains of an Antibody Can Assemble on Blood Coagulation Factor VIII into a Functional Fv-like Complex.抗体的分离可变结构域可在凝血因子 VIII 上组装成功能性 Fv 样复合物。
Int J Mol Sci. 2022 Jul 23;23(15):8134. doi: 10.3390/ijms23158134.
7
Uncovering Membrane-Bound Models of Coagulation Factors by Combined Experimental and Computational Approaches.通过联合实验和计算方法揭示凝血因子的膜结合模型。
Thromb Haemost. 2021 Sep;121(9):1122-1137. doi: 10.1055/s-0040-1722187. Epub 2021 Jul 2.
8
Factor VIII-antibody structure and membrane binding.VIII 因子抗体结构与膜结合。
Blood. 2021 May 27;137(21):2866-2868. doi: 10.1182/blood.2021010947.
9
The 3.2 Å structure of a bioengineered variant of blood coagulation factor VIII indicates two conformations of the C2 domain.凝血因子VIII生物工程变体的3.2 Å结构表明C2结构域存在两种构象。
J Thromb Haemost. 2020 Jan;18(1):57-69. doi: 10.1111/jth.14621. Epub 2019 Sep 8.
10
Enzymatically oxidized phospholipids restore thrombin generation in coagulation factor deficiencies.酶氧化磷脂可恢复凝血因子缺乏症中的凝血酶生成。
JCI Insight. 2018 Mar 22;3(6):98459. doi: 10.1172/jci.insight.98459.